Uses, Dosage & Side Effects: Utibron Inhaler
Utibron Inhaler
| Generic name | indacaterol and glycopyrrolate |
|---|---|
| Drug class | Bronchodilator combination (LABA and anticholinergic) |
| Forms | Inhalation powder in capsules used with the Neohaler inhaler device |
Utibron Neohaler is an inhaled medicine that combines two types of bronchodilators: a long-acting beta2-adrenergic agonist (LABA) called indacaterol and an anticholinergic called glycopyrrolate. It is used long-term to treat chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema. Note: this product has been discontinued in the United States.
Read the full guideUses, dosage, side effects, precautions, and sources, written from the same verified facts.
General information, not medical advice
Your prescriber and the leaflet in your pack know your situation. This page does not.
- Follow your prescriber and the leaflet
- Don't start, stop, or change a dose on your own
- Doses and warnings differ by country and product
Took too much, or feel seriously unwell? Get urgent medical help now.
Facts checked by a personFull disclaimer
